Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress-associated ligands recognized by gamma-delta (γδ) T-cell receptors (TCRs) are a heterogeneous group of molecules upregulated on the surface of cells undergoing physiological stress, such as malignant transformation, oxidative stress, or intracellular infection (Bauer et al., 1999). Unlike conventional alpha-beta (αβ) T cells, which require peptide presentation on MHC molecules, γδ T cells recognize these ligands directly, facilitating a rapid, MHC-independent immune response (Hayday, 2000). Prominent examples include the MHC class I-related chains A and B (MICA/B) and members of the butyrophilin family, specifically BTN3A1 and BTN2A1, which are crucial for the activation of the Vγ9Vδ2 T-cell subset in humans (Rigau et al., 2020). In the context of oncology, these ligands act as molecular signatures of altered self, allowing γδ T cells to identify and eliminate tumor cells while sparing healthy tissue. Therapeutic development in this area focuses on leveraging these interactions through bispecific γδ T-cell engagers or monoclonal antibodies designed to recruit γδ T cells to the tumor microenvironment (Lava Therapeutics, 2023). However, challenges such as the shedding of MICA/B from the cell surface, which creates soluble decoys that inhibit T-cell function, remain significant hurdles in clinical application (Groh et al., 2002).
Activation of gamma-delta T cells through the stabilization or cross-linking of stress-induced ligands with the T-cell receptor, or the accumulation of metabolic intermediates that bind to these ligands to trigger an immune response (Bauer et al., 1999; Rigau et al., 2020).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress-associated ligands recognized by gamma-delta T-cell receptor (γδ TCR ligands) (γδ TCR ligands).